
SetPoint Medical
setpointmedical.comDeveloper of an implantable bioelectronic medical device designed to modulate neuroimmune pathways for reducing inflammation and restoring immunologic balance in chronic autoimmune conditions.
Last Round
Oct 2025
$1.51
Later Stage VC · $480.0M
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Explore related companies
More company profiles from the LBX Pro directory.